Literature DB >> 19091591

Alternatives to transplantation in the surgical therapy for heart failure.

Francesco Nicolini1, Tiziano Gherli.   

Abstract

Despite considerable improvements in the medical treatment of heart failure (HF), the gold standard for the treatment of these patients remains heart transplantation. Nevertheless, in consideration of the shortage of organ donors, this procedure can be offered only to a small percentage of patients who could benefit from a new heart. A number of innovative approaches are being investigated in terms of improved survival and quality of life in patients refractory to medical therapy and excluded from cardiac transplantation lists. These procedures include the optimization of medical therapy, coronary artery bypass surgery and valve surgery in high-risk patients, ventricular restoration techniques, and the implantation of ventricular assist devices as destination therapy. Future therapies for HF could include stem cell therapy, associated with standard revascularization techniques or with other procedures such as ventricular assist devices implantation or ventricular restoration techniques, allowing the potential differentiation of implanted stem cells in a resting and unloaded heart. The modern approach to surgical treatment of HF is multidisciplinary, given that the number of alternative available options to heart transplantation requires a close collaboration between both cardiologists and cardiac surgeons in treating patients with end-stage HF who are not candidates for transplant.

Entities:  

Mesh:

Year:  2008        PMID: 19091591     DOI: 10.1016/j.ejcts.2008.11.003

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Double tunnel technique for the LVAD driveline: improved management regarding driveline infections.

Authors:  David Schibilsky; Christoph Benk; Christoph Haller; Michael Berchtold-Herz; Matthias Siepe; Friedhelm Beyersdorf; Christian Schlensak
Journal:  J Artif Organs       Date:  2011-10-11       Impact factor: 1.731

Review 2.  Cardiovascular Organ-on-a-Chip Platforms for Drug Discovery and Development.

Authors:  João Ribas; Hossein Sadeghi; Amir Manbachi; Jeroen Leijten; Katelyn Brinegar; Yu Shrike Zhang; Lino Ferreira; Ali Khademhosseini
Journal:  Appl In Vitro Toxicol       Date:  2016-06-01

Review 3.  Posterior ventricular restoration treatment for heart failure: a review, past, present and future aspects.

Authors:  Tadashi Isomura; Yasuhisa Fukada; Takuya Miyazaki; Minoru Yoshida; Akimasa Morisaki; Masahiro Endo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-04

4.  Thoratec paracorporeal biventricular assist device therapy: the Freiburg experience.

Authors:  Kerstin Brehm; Claudia Heilmann; Matthias Siepe; Christoph Benk; Friedhelm Beyersdorf; Christian Schlensak
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

5.  Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling.

Authors:  Hye Sook Shin; Akshara Thakore; Yuko Tada; Albert J Pedroza; Gentaro Ikeda; Ian Y Chen; Doreen Chan; Kevin J Jaatinen; Shin Yajima; Eric M Pfrender; Masashi Kawamura; Phillip C Yang; Joseph C Wu; Eric A Appel; Michael P Fischbein; YJoseph Woo; Yasuhiro Shudo
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

6.  Enhanced gap junction expression in myoblast-containing engineered tissue.

Authors:  Sureshkumar Perumal Srinivasan; Klaus Neef; Philipp Treskes; Oliver J Liakopoulos; Christof Stamm; Douglas B Cowan; Navid Madershahian; Elmar Kuhn; Ingo Slottosch; Thorsten Wittwer; Thorsten Wahlers; Yeong-Hoon Choi
Journal:  Biochem Biophys Res Commun       Date:  2012-05-10       Impact factor: 3.575

Review 7.  New Insights in the Diagnosis and Treatment of Heart Failure.

Authors:  Giulio Agnetti; Massimo F Piepoli; Giuseppe Siniscalchi; Francesco Nicolini
Journal:  Biomed Res Int       Date:  2015-10-26       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.